Metraipolis › archive › dc_b4dca3893f08
Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A… — Europe PMC PMID:42792865
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42792865
- DOI
- 10.3390/biomedicines14092125
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T02:28:53.627Z
- SHA-256 of the archived text
db51ae2a4764de4d03aa1bf5328c1819fdc0017dd00c75295eb94b4f1b78ab3c- Stable URL of this page
https://metraipolis.com/documento/dc_b4dca3893f08
How to cite
Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A… — Europe PMC PMID:42792865 — Europe PMC (en), https://europepmc.org/article/MED/42792865 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b4dca3893f08 (Metraipolis archive dc_b4dca3893f08, sha256 db51ae2a4764de4d03aa1bf5328c1819fdc0017dd00c75295eb94b4f1b78ab3c)
BibTeX
@misc{dcb4dca3893f08,
title = {Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A… — Europe PMC PMID:42792865},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42792865},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b4dca3893f08; sha256 db51ae2a4764de4d03aa1bf5328c1819fdc0017dd00c75295eb94b4f1b78ab3c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42792865. Agents can read the archived copy with the MCP tool read_document.